Previous Page  2 / 8 Next Page
Information
Show Menu
Previous Page 2 / 8 Next Page
Page Background

Page 12

ISSN:2171-6625

http://www.jneuro.com

September 18-19, 2017 | Dallas, USA

4

th

International Conference on

NEUROLOGY AND NEUROIMMUNOLOGY

Notes:

A

utoimmune Encephalitis or pediatric autoimmune

neuropsychiatric disorders associated with streptococcal

infections (or PANDAS) is a disease that commonly has an

epitope association with Streptococcus pyogenes (group A

streptococci). The molecular memory between strep surface

proteins and lysogangliosides, tubulin, pyruvate kinase,

enolase, basal ganglia, dopamine D1, D2, Rapid strep or throat

culture, ASO titers, DNase antibodies, Myelin basic protein

antibodies, Alpha and beta Tubulin, Asiaganglioside , Cerebellar

antibodies, Synapsin antibodies, GAD-65 antibodies, Dopamine

D1 receptor antibodies, Dopamine D2 receptor antibodies,

Lysogangliosides antibodies and CaM Kinase II antibodies are

an important immunological component of understanding this

disease. Looking at the interaction between the immune system

and the brain and the basal ganglionic circuitry is imperative

when discussing hyper and hypokinetic disorders. Diagnosis,

management and outcomes of beta retrospective early

analyses is will be discussed while looking at the exploration

or two arms trials that are blinded, placeboed and controlled.

These antibodies in the brain create a probability of generating

tics, obsessive compulsive disorder (OCD) and its relationship to

Sydenham chorea (SC), which is the neurologic manifestation

of acute rheumatic fever. Other cognitive and movement

manifestations may develop in someone afflicted with the

condition.

Speaker Biography

Dr. Joel Brandon Brock is a Certified doctorate level trained Family Nurse Practitioner

and a Diplomate in Functional Neurology, integrated medicine, and nutrition as well.

In Dallas, Texas he serves as a clinician at Foundation Physicians Group. Dr. Brock

has a passion for treating patients from pediatric to geriatric age groups as well as

lecturing and giving learners didactic and academic skills in a way that is easy to

digest, comprehend and utilize in a clinical setting. He has developed thousands of

multidisciplinary hours of curriculum pertaining to neurology, nutrition, physical

diagnosis, pharmacology, immunology, endocrinology and this has impacted students

of multiple educational backgrounds, including medical doctors, nurse practitioners,

chiropractors and more. He enjoys teaching and providing education and support to

facilitate learning for multiple groups and agencies. This includes state association

meetings to 2 governmental panels, and for his own lecture companies. Dr. Brock

enjoys the development and administration of lectures and seminars of all types. Dr.

Brock received the most outstanding functional neurology teacher of the year from the

ACA council of Neurology four years straight and two times from IAFNR (International

Association of Functional Neurology and Rehabilitation). Dr. Brock received the

humanitarian award from IAFNR. Dr. Brock and is also the honorable recipient of

the prestigious Living Legacy Award from Samford Universities Ida Moffett School

Nursing in 2015. Currently Dr. Brock is a Doctorate of Nursing Practice from Duke

University and a global clinical research scholar from Harvard University. Dr. Brock’s

unique blend of clinical and teaching experience along with a background in medicine,

chiropractic, neurology and nutrition has created a very unique and integrated clinical

background that has helped him treat difficult cases and offers comprehensive and

multi-perspective angles on education and clinical presentations. His greatest desire in

life is to help those with chronic health problems.

e:

Drbrocktwu@gmail.com

Joel Brandon Brock

Cerebrum Health Centers, USA

Autoimmune encephalitis: The neuroimmunology of pediatric movement disorders

and cognitive changes post infection: A functional integrative neurology approach

Joel Brandon Brock, J Neurol Neurosci, 8:5

DOI: 10.21767/2171-6625-C1-001